News
SCLX
1.740
+2.35%
0.040
Weekly Report: what happened at SCLX last week (1102-1106)?
Weekly Report · 1d ago
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Benzinga · 3d ago
Datavault AI Fires CEO Nathaniel Bradley
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/02 12:05
Weekly Report: what happened at SCLX last week (1026-1030)?
Weekly Report · 11/02 09:41
Datavault AI Stock (DVLT) Plunges Nearly 50% over $150 Million Bitcoin Controversy Before Rebounding 22% Today
TipRanks · 10/28 16:50
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
Benzinga · 10/27 16:31
Weekly Report: what happened at SCLX last week (1019-1023)?
Weekly Report · 10/26 09:41
Datavault signs non-binding LOI to acquire 19.9% stake in DataMEDS AI
TipRanks · 10/22 12:17
DataMEDS AI enters amended, restated LOI to license, acquire IP
TipRanks · 10/22 11:45
DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042
Benzinga · 10/22 11:44
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/20 12:05
Weekly Report: what happened at SCLX last week (1012-1016)?
Weekly Report · 10/19 09:41
Weekly Report: what happened at SCLX last week (1005-1009)?
Weekly Report · 10/12 09:44
Weekly Report: what happened at SCLX last week (0928-1002)?
Weekly Report · 10/05 09:44
Scilex Expands Credit Facility Support for Vivasor Affiliate
TipRanks · 09/29 20:33
Weekly Report: what happened at SCLX last week (0921-0925)?
Weekly Report · 09/28 09:41
Weekly Report: what happened at SCLX last week (0914-0918)?
Weekly Report · 09/21 09:41
Weekly Report: what happened at SCLX last week (0907-0911)?
Weekly Report · 09/14 09:44
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More
Seeking Alpha · 09/11 19:53
More
Webull provides a variety of real-time SCLX stock news. You can receive the latest news about Scilex Holding Co through multiple platforms. This information may help you make smarter investment decisions.
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.